Quercetin-Loaded Nanoparticles: A Promising Therapeutic Strategy for Inflammatory Bowel Disease
Journal of Inflammation Research · 2025-09 · Volume 18 · 12447-12461
DOI: 10.2147/jir.s545203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2025-09. Verfasst von Wenpeng Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic I, Kussmaul Campus for Medical Research, University of Erlangen-Nürnberg, Erlangen, Germany. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Clinic I, Kussmaul Campus for Medical Research, University of Erlangen-Nürnberg, Erlangen, Germany.
- Department of Colorectal Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digesti…
- Department of Endocrinology, Dazhou Central Hospital, Dazhou, People's Republic of China.
- FAU Profile Center Immunomedicine, University of Erlangen-Nürnberg, Erlangen, Germany.
Zitieren
APA
Wang, W., Li, M., Liu, Y., & Weigmann, B. (2025). Quercetin-Loaded Nanoparticles: A Promising Therapeutic Strategy for Inflammatory Bowel Disease. Journal of Inflammation Research, Volume 18, 12447-12461. https://doi.org/10.2147/jir.s545203
Vancouver
Wang W, Li M, Liu Y, Weigmann B. Quercetin-Loaded Nanoparticles: A Promising Therapeutic Strategy for Inflammatory Bowel Disease. Journal of Inflammation Research. 2025;Volume 18:12447-12461. doi:10.2147/jir.s545203
BibTeX
@article{Wang2025,
author = {Wang, Wenpeng and Li, Mingrui and Liu, Ying and Weigmann, Benno},
title = {Quercetin-Loaded Nanoparticles: A Promising Therapeutic Strategy for Inflammatory Bowel Disease},
journal = {Journal of Inflammation Research},
year = {2025},
volume = {Volume 18},
pages = {12447--12461},
doi = {10.2147/jir.s545203}
}
EUVIMED